RhumbLine Advisers’s Global Medical REIT GMRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $793K | Buy |
114,429
+10,141
| +10% | +$70.3K | ﹤0.01% | 2370 |
|
2025
Q1 | $913K | Sell |
104,288
-4,574
| -4% | -$40K | ﹤0.01% | 2221 |
|
2024
Q4 | $840K | Buy |
108,862
+2,731
| +3% | +$21.1K | ﹤0.01% | 2330 |
|
2024
Q3 | $1.05M | Sell |
106,131
-4,211
| -4% | -$41.7K | ﹤0.01% | 2244 |
|
2024
Q2 | $1M | Buy |
110,342
+5,696
| +5% | +$51.7K | ﹤0.01% | 2246 |
|
2024
Q1 | $916K | Sell |
104,646
-2,379
| -2% | -$20.8K | ﹤0.01% | 2302 |
|
2023
Q4 | $1.19M | Buy |
107,025
+426
| +0.4% | +$4.73K | ﹤0.01% | 2165 |
|
2023
Q3 | $956K | Sell |
106,599
-397
| -0.4% | -$3.56K | ﹤0.01% | 2236 |
|
2023
Q2 | $977K | Sell |
106,996
-1,035
| -1% | -$9.45K | ﹤0.01% | 2302 |
|
2023
Q1 | $984K | Buy |
108,031
+2,238
| +2% | +$20.4K | ﹤0.01% | 2125 |
|
2022
Q4 | $1M | Buy |
105,793
+1,444
| +1% | +$13.7K | ﹤0.01% | 2125 |
|
2022
Q3 | $889K | Buy |
104,349
+5,188
| +5% | +$44.2K | ﹤0.01% | 2194 |
|
2022
Q2 | $1.11M | Buy |
99,161
+12,457
| +14% | +$140K | ﹤0.01% | 2084 |
|
2022
Q1 | $1.42M | Sell |
86,704
-358
| -0.4% | -$5.84K | ﹤0.01% | 1978 |
|
2021
Q4 | $1.55M | Buy |
87,062
+1,527
| +2% | +$27.1K | ﹤0.01% | 2015 |
|
2021
Q3 | $1.26M | Buy |
85,535
+6,048
| +8% | +$88.9K | ﹤0.01% | 2131 |
|
2021
Q2 | $1.17M | Buy |
79,487
+8,186
| +11% | +$121K | ﹤0.01% | 2173 |
|
2021
Q1 | $935K | Sell |
71,301
-2,817
| -4% | -$36.9K | ﹤0.01% | 2218 |
|
2020
Q4 | $968K | Buy |
74,118
+9,628
| +15% | +$126K | ﹤0.01% | 2142 |
|
2020
Q3 | $871K | Sell |
64,490
-13,868
| -18% | -$187K | ﹤0.01% | 2046 |
|
2020
Q2 | $888K | Buy |
78,358
+13,262
| +20% | +$150K | ﹤0.01% | 2090 |
|
2020
Q1 | $659K | Buy |
65,096
+13,661
| +27% | +$138K | ﹤0.01% | 2051 |
|
2019
Q4 | $680K | Buy |
51,435
+2,218
| +5% | +$29.3K | ﹤0.01% | 2239 |
|
2019
Q3 | $561K | Buy |
49,217
+4,742
| +11% | +$54.1K | ﹤0.01% | 2274 |
|
2019
Q2 | $467K | Buy |
44,475
+12,095
| +37% | +$127K | ﹤0.01% | 2390 |
|
2019
Q1 | $318K | Sell |
32,380
-42,843
| -57% | -$421K | ﹤0.01% | 2515 |
|
2018
Q4 | $669K | Buy |
75,223
+52,755
| +235% | +$469K | ﹤0.01% | 2165 |
|
2018
Q3 | $212K | Buy |
22,468
+881
| +4% | +$8.31K | ﹤0.01% | 2702 |
|
2018
Q2 | $191K | Buy |
21,587
+4,555
| +27% | +$40.3K | ﹤0.01% | 2747 |
|
2018
Q1 | $118K | Buy |
17,032
+610
| +4% | +$4.23K | ﹤0.01% | 2717 |
|
2017
Q4 | $135K | Sell |
16,422
-2,422
| -13% | -$19.9K | ﹤0.01% | 2728 |
|
2017
Q3 | $169K | Buy |
18,844
+1,145
| +6% | +$10.3K | ﹤0.01% | 2797 |
|
2017
Q2 | $158K | Buy |
17,699
+5,710
| +48% | +$51K | ﹤0.01% | 2820 |
|
2017
Q1 | $109K | Buy |
11,989
+1,490
| +14% | +$13.5K | ﹤0.01% | 2768 |
|
2016
Q4 | $94K | Buy |
+10,499
| New | +$94K | ﹤0.01% | 2798 |
|